Latest News
Apimeds Pharmaceuticals US, Inc.
- Why Is Apimeds Pharmaceuticals US (NYSEAMERICAN:APUS) Up 8.29% Pre-Market on Tuesday? The Catalyst, the Fundamentals and What Comes Next
- Apimeds Pharmaceuticals US (NYSE American: APUS) Announces MindWave NILA Token Listing on Pionex Exchange
- Apimeds Subsidiary MindWave Signs Three Blockchain Network Deals Across Climate Finance, Sports Media, and Insurance
- MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure
- Why Did Apimeds (NYSEAMERICAN:APUS) Jump 55.3% After 42.5%?
- Form 8K Apimeds Pharmaceuticals US For: 1 October By Investing.com
- Apimeds Pharmaceuticals US inks two 12-month MindChain service deals for AQUAEChain and FlashChain
- Apimeds Pharmaceuticals US (NYSE American: APUS) Subsidiary MindWave Innovations Signs 12-Month Agreement to Build FlashChain
- Apimeds Pharmaceuticals Shares Surge 146% on AQUAEChain Technology Deal
- Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest
- Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening?
- 12 Health Care Stocks Moving In Thursday's Intraday Session - Apimeds Pharmaceuticals (AMEX:APUS), Surroz
Headlines from the last 30 days, linking to the original publishers. See all market news →